Outcomes of children with intermediate-risk neuroblastoma after treatment stratified by MYCN status and tumor cell ploidy.

MLA

Bagatell, Rochelle, et al. “Outcomes of Children with Intermediate-Risk Neuroblastoma after Treatment Stratified by MYCN Status and Tumor Cell Ploidy.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 23, no. 34, Dec. 2005, pp. 8819–27. EBSCOhost, https://doi.org/10.1200/JCO.2004.00.2931.

APA

Bagatell, R., Rumcheva, P., London, W. B., Cohn, S. L., Look, A. T., Brodeur, G. M., Frantz, C., Joshi, V., Thorner, P., Rao, P. V., Castleberry, R., & Bowman, L. C. (2005). Outcomes of children with intermediate-risk neuroblastoma after treatment stratified by MYCN status and tumor cell ploidy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 23(34), 8819–8827. https://doi.org/10.1200/JCO.2004.00.2931

Chicago

Bagatell, Rochelle, Pavlina Rumcheva, Wendy B London, Susan L Cohn, A Thomas Look, Garrett M Brodeur, Christopher Frantz, et al. 2005. “Outcomes of Children with Intermediate-Risk Neuroblastoma after Treatment Stratified by MYCN Status and Tumor Cell Ploidy.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 23 (34): 8819–27. doi:10.1200/JCO.2004.00.2931.